We are live on ! Find out more
VCRE

Vicore Pharma Holding

5 hedge funds and large institutions have $13.6M invested in Vicore Pharma Holding in 2026 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

5.06% more ownership

Funds ownership: 0% → 5.06% (+5.1%)

Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.06%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

VCRE Hedge Fund Activity: Q3 2026 in Review

5 of the 8,221 institutional investors tracked by Wall St. Rank reported a position in Vicore Pharma Holding (VCRE) for Q3 2026, worth a combined $13.6M.

Buyers outnumbered sellers: 5 funds opened new VCRE positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Folketrygdfondet, opening a new position worth an estimated $11.3M.

  • 5 institutional investors held Vicore Pharma Holding (VCRE) as of Q3 2026, up from 0 in Q2 2026.
  • Funds reported $13.6M of Vicore Pharma Holding stock for Q3 2026.
  • 5 funds opened new Vicore Pharma Holding positions in Q3 2026 and 0 closed out, a net change of +5 holders.
  • The largest Vicore Pharma Holding buyer in Q3 2026 was Folketrygdfondet, an estimated $11.3M added.

Based on aggregated 13F filings for Q3 2026.